We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+7.25%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$76.2B
AUM Growth
+$3.6B
(+5%)
Cap. Flow
-$379M
Cap. Flow
% of AUM
-0.5%
Top 10 Holdings %
Top 10 Hldgs %
46.27%
Holding
781
New
70
Increased
299
Reduced
299
Closed
89
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$510M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 3 |
Builders FirstSource
BLDR
|
+$110M |
| 4 |
Amazon
AMZN
|
+$91.9M |
| 5 |
Natixis Loomis Sayles Focused Growth ETF
LSGR
|
+$77.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$114M |
| 2 |
Meta Platforms (Facebook)
META
|
+$87.2M |
| 3 |
Netflix
NFLX
|
+$77.3M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$65.6M |
| 5 |
Accenture
ACN
|
+$58.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.59% |
| 2 | Consumer Discretionary | 17.53% |
| 3 | Communication Services | 17.38% |
| 4 | Healthcare | 13.08% |
| 5 | Financials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Vanguard FTSE Emerging Markets ETF
VWO
$126B
| $3.73M | ﹤0.01% |
+77,876
| New | +$3.47M |
|
402
ICICI Bank
IBN
$108B
| $3.3M | ﹤0.01% |
110,436
-105,537
| -49% | -$3.07M |
|
403
Teledyne Technologies
TDY
$32B
| $3.16M | ﹤0.01% |
7,215
-32,762
| -82% | -$13.6M |
|
404
iShares Core S&P Small-Cap ETF
IJR
$112B
| $3.1M | ﹤0.01% |
26,482
+26,137
| +7,576% | +$2.95M |
|
405
iHeartMedia
IHRT
$561M
| $2.72M | ﹤0.01% |
1,468,409
-1,845
| -0.1% | -$2.75K |
|
406
Jones Lang LaSalle
JLL
$16.4B
| $2.05M | ﹤0.01% |
+7,606
| New | +$1.84M |
|
407
Battalion Oil
BATL
$31M
| $1.67M | ﹤0.01% |
250,868
-6,275
| -2% | -$23.6K |
|
408
Eli Lilly
LLY
$1.1T
| $1.66M | ﹤0.01% |
1,869
+370
| +25% | +$333K |
|
409
Estee Lauder
EL
$31.5B
| $1.54M | ﹤0.01% |
15,462
+2
| +0% | +$190 |
|
410
Caterpillar
CAT
$385B
| $1.51M | ﹤0.01% |
3,854
+2,105
| +120% | +$727K |
|
411
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.7B
| $1.25M | ﹤0.01% |
+13,600
| New | +$1.25M |
|
412
ServiceNow
NOW
$132B
| $1.14M | ﹤0.01% |
6,385
+475
| +8% | +$78.1K |
|
413
Vipshop
VIPS
$7.4B
| $1.11M | ﹤0.01% |
70,396
+6,278
| +10% | +$84K |
|
414
Booking.com
BKNG
$160B
| $1.08M | ﹤0.01% |
6,400
+275
| +4% | +$42.2K |
|
415
Leonardo DRS
DRS
$12B
| $1.01M | ﹤0.01% |
35,889
-703,230
| -95% | -$19.3M |
|
416
Progressive
PGR
$124B
| $971K | ﹤0.01% |
3,825
+3,307
| +638% | +$769K |
|
417
iShares MSCI India Small-Cap ETF
SMIN
$772M
| $949K | ﹤0.01% |
11,033
+7,882
| +250% | +$658K |
|
418
Carlisle Companies
CSL
$15.3B
| $935K | ﹤0.01% |
+2,080
| New | +$860K |
|
419
DoorDash
DASH
$90.9B
| $932K | ﹤0.01% |
6,531
+5,987
| +1,101% | +$726K |
|
420
AT&T
T
$165B
| $931K | ﹤0.01% |
42,309
+38,113
| +908% | +$758K |
|
421
Hilton Worldwide
HLT
$70B
| $878K | ﹤0.01% |
3,810
-1,555
| -29% | -$337K |
|
422
Applied Materials
AMAT
$415B
| $850K | ﹤0.01% |
4,208
+296
| +8% | +$60.7K |
|
423
Altria Group
MO
$109B
| $849K | ﹤0.01% |
16,641
+6,907
| +71% | +$349K |
|
424
Edison International
EIX
$26.1B
| $764K | ﹤0.01% |
8,774
+8,590
| +4,668% | +$698K |
|
425
Cardinal Health
CAH
$55.5B
| $756K | ﹤0.01% |
6,836
+5,925
| +650% | +$619K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q3 2024 Portfolio in Review
As of Q3 2024, Loomis, Sayles & Company held 781 positions worth $76.2B, up 5% from $72.6B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Loomis, Sayles & Company's Q3 2024 filing shows 70 new, 299 increased, 299 reduced and 89 closed positions. Its largest new stake was Rhythm Pharmaceuticals: 636,628 shares worth $33.4M. The largest sale was Oracle, an estimated $114M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Loomis, Sayles & Company's largest Q3 2024 buy was Rhythm Pharmaceuticals: 636,628 shares worth $33.4M.
- Loomis, Sayles & Company added most to Nike in Q3 2024, an estimated $510M increase.
- Loomis, Sayles & Company's biggest Q3 2024 reduction was Oracle, cutting an estimated $114M.
- Loomis, Sayles & Company fully exited Simply Good Foods in Q3 2024, selling an estimated $58.7M.
- Loomis, Sayles & Company's ten largest holdings make up 46% of its $76.2B portfolio in Q3 2024.
- Loomis, Sayles & Company opened 70 new positions and closed 89 in Q3 2024.
- Loomis, Sayles & Company's portfolio value rose 5% quarter-over-quarter to $76.2B.
Based on Loomis, Sayles & Company's 13F filing for Q3 2024, filed 13 Nov 2024.